My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0671
    CAS No. (CAS Registry Number): 641571-10-0
    Description: Nilotinib (formerly also known as AMN-107, AMN107) is a potent, orally bioavailable aminopyrimidine-derivative Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenito...
    Catalog No: V0672
    CAS No. (CAS Registry Number): 839706-07-9
    Description: GNF-7 is a novel, potent, oral bioactive type-II kinase Bcr-Abl inhibitor with IC50 ofReferences: J Med Chem. 2010 Aug 12;53(15):5439-48; Blood. 2015 May 14;...
    Catalog No: V0673
    CAS No. (CAS Registry Number): 926037-48-1
    Description: Radotinib (formerly also known as IY-5511) is a novel, potent, selective, orally bioavailable, and second-generation BCR-ABL1 tyrosine kinase inhibitor with IC50 of 34 nM. It is...
    Catalog No: V0674
    CAS No. (CAS Registry Number): 778277-15-9
    Description: GNF-5, a GNF-2 analog with improved pharmacokinetic properties,  is a novel, potent, selective and allosteric/non-ATP competitive Bcr-Abl inhibitor with IC50 of 220 nM for ...
    Catalog No: V0675
    CAS No. (CAS Registry Number): 1421783-64-3
    Description: GZD824 Dimesylate, the dimesylate salt of GZD824 (HQP1351), is a novel, potent orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM...
    Catalog No: V0676
    CAS No. (CAS Registry Number): 260415-63-2
    Description: PD173955, a src-selective tyrosine kinase inhibitor, is a novel and potent Bcr-Abl inhibitor with IC50 of 1-2 nM, it also inhibits Src activity with IC50 of 22 nM. PD173955 show...
    10页次1/2首页<12>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Email: sales@invivochem.com
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved